Nellcor OxiFirst Verdict Contingent On NIH FOX Trial Results, Panel Agrees

Upgraded software for Nellcor's OxiFirst N400 fetal pulse oximetry system will be included in NIH's Fetal Oximetry trial (FOX), as the company attempts to ward off adverse events associated with misuse of the device